Treatment of Vaginal Irritation
Vaginal irritation requires identification of the underlying cause through pH testing and microscopic examination, followed by targeted antimicrobial therapy for infectious causes or removal of irritants for non-infectious causes. 1
Diagnostic Approach
The evaluation must include:
- Vaginal pH measurement using narrow-range pH paper, where pH >4.5 suggests bacterial vaginosis or trichomoniasis, while pH ≤4.5 indicates vulvovaginal candidiasis or non-infectious causes 1
- Microscopic examination of vaginal discharge diluted in saline (to identify motile trichomonads or clue cells) and 10% KOH (to visualize yeast or pseudohyphae) 1, 2
- "Whiff test" by adding KOH to discharge—a fishy amine odor indicates bacterial vaginosis or trichomoniasis 1
- Assessment for vulvar inflammation in the absence of vaginal pathogens, which suggests mechanical or chemical irritation 1
Treatment Algorithm by Etiology
Bacterial Vaginosis (40-50% of cases when cause identified)
Symptomatic bacterial vaginosis should be treated with oral metronidazole 500 mg twice daily for 7 days. 3
Alternative regimens include:
- Metronidazole gel 0.75% intravaginally for 5 days 3
- Clindamycin cream 2% intravaginally for 7 days 3
- Clindamycin 300 mg orally twice daily for 7 days 3
Treatment of male partners is not recommended as it does not alter clinical course or prevent recurrence 1
Vulvovaginal Candidiasis (20-25% of cases)
Topical azole antifungals are first-line treatment and equally effective as oral fluconazole. 1, 2
Recommended intravaginal regimens:
- Clotrimazole 1% cream 5g for 7-14 days 1
- Miconazole 2% cream 5g for 7 days 1
- Terconazole 0.4% cream 5g for 7 days 1
- Single-dose options: Clotrimazole 500mg tablet or Tioconazole 6.5% ointment 5g 1
Oral fluconazole 150mg as a single dose is an alternative for uncomplicated cases 1
For severe or complicated cases, use multi-day regimens (7 days) rather than single-dose treatments. 1
Trichomoniasis (15-20% of cases)
Oral metronidazole 2g as a single dose is the standard treatment, with equal efficacy to 500mg twice daily for 7 days. 3
Alternative: Tinidazole 2g orally as a single dose 4
Sexual partners must be treated simultaneously to prevent reinfection, even without screening 1, 3
Non-Infectious Irritation
When objective signs of vulvar inflammation exist without vaginal pathogens and minimal discharge, mechanical or chemical irritation is likely. 1
Management includes:
- Discontinue potential irritants including harsh soaps, douches, scented products, and tight-fitting synthetic clothing 5, 2
- Use gentle cleansing with warm water only 6, 7
- Wear cotton underwear changed daily 6, 7
- For ingrown hairs causing irritation, clip rather than shave to reduce further trauma 5
Important Clinical Pitfalls
Self-medication with over-the-counter antifungal preparations should only be advised for women previously diagnosed with vulvovaginal candidiasis who experience identical recurrent symptoms. 1 Inappropriate self-treatment can delay proper diagnosis and treatment of other conditions 5.
Culture for Candida species in the absence of symptoms should not lead to treatment, as 10-20% of asymptomatic women harbor Candida in the vagina 1
Laboratory testing fails to identify a cause in a substantial minority of women, requiring empiric management based on clinical presentation 1
Special Populations
Pregnancy
- Metronidazole 2g single dose can be used after the first trimester for bacterial vaginosis and trichomoniasis 1
- Only topical azoles are recommended for vulvovaginal candidiasis during pregnancy; oral fluconazole should be avoided 1, 2
- Treatment of symptomatic trichomoniasis in pregnancy is warranted to prevent preterm birth 3
Recurrent Vulvovaginal Candidiasis (≥4 episodes/year)
- Maintenance therapy with oral fluconazole 150mg weekly for up to 6 months enhances treatment success 3
Follow-Up Requirements
Women whose symptoms persist after treatment or who experience recurrence within 2 months should seek medical evaluation. 1 Test of cure is not routinely recommended for trichomoniasis treated with metronidazole 3, but persistent symptoms may indicate treatment-resistant cases requiring higher-dose therapy 3.